These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4502399)

  • 1. Levo-dihydroxyphenylalanine--Parkinson's disease and manganese poisoning.
    Goldman ME
    IMS Ind Med Surg; 1972 Apr; 41(4):12-5. PubMed ID: 4502399
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic modification of some neurologic disorders.
    Cotzias GC
    JAMA; 1969 Nov; 210(7):1255-62. PubMed ID: 5394649
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D
    Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic modification of Parkinson's disease and of chronic manganese poisoning.
    Cotzias GC; Papavasiliou PS; Ginos J; Steck A; Düby S
    Annu Rev Med; 1971; 22():305-26. PubMed ID: 4944422
    [No Abstract]   [Full Text] [Related]  

  • 6. The biochemistry of catecholamines in relation to Parkinson's disease.
    Hinterberger H
    Aust N Z J Med; 1971 May; 1():Suppl 1:14-8. PubMed ID: 5292808
    [No Abstract]   [Full Text] [Related]  

  • 7. L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.
    Mars H; Libman I; Schwartz AM; Gillo-Joffroy L; Barbeau A
    Can Psychiatr Assoc J; 1972 Apr; 17(2):123-31. PubMed ID: 5036506
    [No Abstract]   [Full Text] [Related]  

  • 8. [The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations].
    Morselli PL; Rizzo M; Tognoni G
    Recenti Prog Med; 1970 Feb; 48(2):97-124. PubMed ID: 5467589
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].
    Shibazaki H
    Shinkei Kenkyu No Shimpo; 1971; 15(4):992-1002. PubMed ID: 4400830
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
    Sigwald J
    Therapeutique; 1972 Nov; 48(9):561-8. PubMed ID: 4650525
    [No Abstract]   [Full Text] [Related]  

  • 11. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
    Miller EM; Wiener L
    Neurology; 1974 May; 24(5):482-6. PubMed ID: 4857107
    [No Abstract]   [Full Text] [Related]  

  • 12. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W
    Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
    [No Abstract]   [Full Text] [Related]  

  • 13. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here?
    Clin Pharmacol Ther; 1971; 12(2):408-16. PubMed ID: 5577487
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical aspect of Parkinson's disease].
    Nakajima T
    No To Shinkei; 1968 Nov; 20(11):1089-94. PubMed ID: 4887196
    [No Abstract]   [Full Text] [Related]  

  • 15. L-dopa in Parkinson's syndrome.
    Poskanzer DC
    N Engl J Med; 1969 Feb; 280(7):382-3. PubMed ID: 5764823
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinson's syndrome. Recent progress in the medical treatment and its pharmacological basis.
    Shibasaki H
    Minn Med; 1971 Oct; 54(10):839-49. PubMed ID: 4398771
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa in the treatment of Parkinsonism.
    Cotzias GC
    JAMA; 1971 Dec; 218(13):1903-8. PubMed ID: 5171066
    [No Abstract]   [Full Text] [Related]  

  • 18. [L-dopa and Parkinson's disease].
    Barbeau A
    Union Med Can; 1970 Dec; 99(12):2195-7. PubMed ID: 5488646
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of parkinsonism with levodopa.
    Sutcliffe RL
    Gerontol Clin (Basel); 1974; 16(1):151-6. PubMed ID: 4855131
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1972 Jun; 47(6):389-95. PubMed ID: 5041685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.